# Sobhagya Mercan (NSE: SOBME) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SOBME · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹864 Cr, it ranks 1544th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Financials sector; its industry is Other Industrial Metals & Mining.

Its return on equity was 19.4% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹82 Cr (+43.9% year on year) and net profit ₹6 Cr (−25.2%), on a standalone basis. Promoters held 60.58% of the company as of 13 Jul 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹864 Cr |
| ROE | 19.4% (FY25) |
| ROCE | 31.1% (FY25) |
| Debt to equity | 0.08 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹82 Cr | +43.9% | ₹6 Cr | −25.2% | ₹7.88 |
| Q3 FY26 | ₹47 Cr | +8.9% | ₹6 Cr | +65.8% | ₹7.20 |
| Q2 FY26 | ₹51 Cr | +85.6% | ₹5 Cr | +122.7% | ₹5.64 |
| Q1 FY26 | ₹52 Cr | +113.5% | ₹6 Cr | +155.5% | ₹6.77 |
| Q4 FY25 | ₹57 Cr | +78.9% | ₹8 Cr | +92.4% | ₹10.58 |
| Q3 FY25 | ₹44 Cr | +64.2% | ₹4 Cr | +69.0% | ₹4.38 |
| Q2 FY25 | ₹28 Cr | +21.5% | ₹2 Cr | +1.0% | ₹2.48 |
| Q1 FY25 | ₹25 Cr | −28.6% | ₹2 Cr | −34.7% | ₹2.69 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹157 Cr | ₹16 Cr |
| FY24 | ₹115 Cr | ₹12 Cr |
| FY23 | ₹109 Cr | ₹11 Cr |
| FY22 | ₹67 Cr | ₹11 Cr |
| FY21 | ₹38 Cr | ₹8 Cr |
| FY20 | ₹6 Cr | ₹6 Cr |

## Shareholding (13 Jul 2026)

- Promoters: 60.58%
- Foreign institutions: 19.22%
- Non-institutions: 20.20%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Centrum Capital](https://app.pivotnow.in/stock/CENTRUM) | ₹18.96 | ₹923 Cr | — | — |
| [Wealth First Portfolio Managers](https://app.pivotnow.in/stock/WEALTH) | ₹854.00 | ₹910 Cr | 23.6 | — |
| [Health X Platform](https://app.pivotnow.in/stock/HEALTHX) | ₹278.75 | ₹887 Cr | — | — |
| [Max India](https://app.pivotnow.in/stock/MAXIND) | ₹157.20 | ₹884 Cr | — | — |
| [Hexa Tradex](https://app.pivotnow.in/stock/HEXATRADEX) | ₹156.39 | ₹864 Cr | — | — |
| [IIRM Holdings](https://app.pivotnow.in/stock/IIRM) | — | ₹856 Cr | — | — |

## Questions and answers

### What is the market cap of Sobhagya Mercan?

Sobhagya Mercan's market capitalisation is ₹864 Cr (₹864 Cr) at the 19 Oct 2026 close, ranking 1544th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Sobhagya Mercan?

Return on equity was 19.4% in FY25 and return on capital employed was 31.1% in FY25 (standalone figures).

### What were Sobhagya Mercan's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Sobhagya Mercan reported revenue of ₹82 Cr, +43.9% year on year, and net profit of ₹6 Cr, −25.2% year on year.

### What is the shareholding pattern of Sobhagya Mercan?

As of 13 Jul 2026: promoters 60.58%, foreign institutions 19.22%, non-institutions 20.20%.

### Who are Sobhagya Mercan's competitors?

The listed Financials companies closest to Sobhagya Mercan by market cap are Centrum Capital, Wealth First Portfolio Managers, Health X Platform, Max India, Hexa Tradex and IIRM Holdings.

### Is Sobhagya Mercan a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Sobhagya Mercan's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SOBME against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.